Skip to content

Advertisement

BMC Complementary and Alternative Medicine

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Evaluation of antinociceptive, in-vivo & in-vitro anti-inflammatory activity of ethanolic extract of Curcuma zedoaria rhizome

  • H M Arif Ullah1,
  • Sayera Zaman2,
  • Fatematuj Juhara2,
  • Lucky Akter2,
  • Syed Mohammed Tareq3,
  • Emranul Haque Masum2 and
  • Rajib Bhattacharjee2Email author
BMC Complementary and Alternative MedicineThe official journal of the International Society for Complementary Medicine Research (ISCMR)201414:346

https://doi.org/10.1186/1472-6882-14-346

Received: 3 February 2014

Accepted: 15 July 2014

Published: 22 September 2014

Abstract

Background

The present study was aimed to investigate the antinociceptive and anti-inflammatory activity of the Curcuma zedoaria (family Zingiberaceae) ethanolic rhizome extract in laboratory using both in vitro and in vivo methods so as to justify its traditional use in the above mentioned pathological conditions.

Methods

Phytochemical screening was done to find the presence of various secondary metabolites of the plant. In vivo antinociceptive activity was performed employing the hot plate method, acidic acid induced writhing test and formalin induced writhing test on Swiss albino mice at doses of 250 and 500 mg/kg body weight. Anti-inflammatory activity test was done on Long Evans rats at two different doses (250 and 500 mg/kg body weight) by using carrageenan induced paw edema test. Finally in vitro anti-inflammatory test by protein-denaturation method was followed. Data were analyzed by one-way analysis of variance (ANOVA) and Dunnett’s t-test was used as the test of significance. P value <0.05 was considered as the minimum level of significance.

Results

Phytochemical screening revealed presence of tannins, saponins, flavonoids, gums & carbohydrates, steroids, alkaloids, reducing sugars and terpenoids in the extract. In the hot plate method, the extract increased the reaction time of heat sensation significantly to 61.99% and 78.22% at the doses of 250 and 500 mg/kg BW respectively. In acetic acid induced writhing test, the percent inhibition of writhing response by the extract was 48.28% and 54.02% at 250 and 500 mg/kg doses respectively (p < 0.001). The extract also significantly inhibited the licking response in both the early phase (64.49%, p < 0.01) and the late phase (62.37%, p < 0.01) in formalin induced writhing test. The extract significantly (p < 0.05, p < 0.01 and p < 0.001) inhibited carrageenan induced inflammatory response in rats in a dose related manner. In in-vitro anti-inflammatory test, the extract significantly inhibited protein denaturation of 77.15, 64.43, 53.04, 36.78 and 23.70% for doses of 500, 400, 300, 200 and 100 μg/mL respectively.

Conclusions

The results obtained from the tests indicate that the plant might have one or more secondary metabolite(s) having central and peripheral analgesic and anti-inflammatory activity.

Keywords

Curcuma zedoaria Antinociceptive activity In-vivo & in-vitro anti-inflammatory activity

Background

The majority population of the developing world relies on traditional herbal medicine as the primary source of treatment for illnesses [1]. The issue of compliance with herbal medicines varies according to local beliefs and socio-cultural status, and is less reliant on the efficacy of the traditional medicine.

About 25% of the drugs prescribed worldwide come from plants, 121 such active compounds being in current use of the 252 drugs considered as basic and essential by the World Health Organization (WHO), 11% are exclusively of plant origin and a significant number are synthetic drugs obtained from natural precursors.

Modern social context and economic view of health services, the needs of the pharmaceutical market and the recognition that research on medicinal plants used in folk medicine represents a suitable approach for the development of new drugs [2, 3] have led to an increase in the number of publications in this field, and private and governmental institutions are now financially supporting research programs worldwide.

It is estimated that, in 1997, the world market for over the-counter phytomedicinal products was US$ 10 billion, with an annual growth of 6.5% [4]. In 2003, growth was well over expectation with sales exceeding USD 65 billion, with USD 9 billion in Europe alone. The WHO considers phytotherapy in its health programs and suggests basic procedures for the validation of drugs from plant origin in developing countries [5]. China and India have a well-established herbal medicines industry and Latin American countries have been investing in research programs in medicinal plants and the standardization and regulation of phytomedicinal products.

As mentioned earlier, interest in herbal medicine as a path to drug development increased greatly in the early 1980s [6]. This could be due to the inefficiency of conventional medicine (e.g. cytotoxicity, side effects and ineffectiveness of synthetic drugs), abusive and incorrect use of synthetic drugs and most importantly, the high cost involved in conventional medicine and the fact that a large percentage of the world’s population does not have access to conventional pharmacological treatment. With the limitations of synthetic chemistry, there also arises the need to find new medicines to combat the emergence of multi-resistant pathogens [6], as well as to manage a whole range of chronic and difficult-to-treat diseases such as cancer, diabetes and AIDS. Natural products offer unmatched structural variety and their usefulness can be extended by probing biological pathways [7].

Inflammation is a complex biological response of vascular tissues to harmful stimuli. It is also a protective attempt by the organism to remove the injurious stimuli and initiate the healing process [8]. At the onset of an inflammation, the cells undergo activation and release inflammatory mediators. These mediators include histamine, serotonin, slow reacting substances of anaphylaxis (SRS-A), prostaglandins and some plasma enzyme systems such as the complement system, the clotting system, the fibrinolytic system and the kinin system [9]. These mediator molecules work collectively to cause increased vasodilatation and permeability of blood vessels. Thus, leading to increased blood flow, exudation of plasma proteins and fluids, and migration of leukocytes, mainly neutrophils, outside the blood vessels into the injured tissues. Inflammation can be classified as either acute or chronic inflammation [8]. Acute inflammation is the initial response of the body to injurious stimuli and is achieved by increased movement of plasma and leukocytes from the blood into the injured tissues. The process of acute inflammation is initiated by cells already present in the tissues. This is characterized by marked vascular changes, including vasodilatation and increased capillary permeability which are induced by the actions of the various inflammatory mediators. Chronic inflammation is a prolonged inflammatory response that leads to a progressive shift in the type of cells present at the site of inflammation and is characterized by simultaneous destruction and healing of the tissues from the inflammatory process.

Zedoary (Curcuma zedoaria) is the name for a perennial herb and member of the genus Curcuma Linn. Family: Zingiberaceae. It is also known as White Turmeric. The plant is native to India and Indonesia. It was introduced to Europe by Arabs around the sixth century, but its use as a spice in the West today is extremely rare, having been replaced by ginger.

Zedoary, also known as white turmeric, is a rhizome with a thin brown skin and a bright orange, hard interior. Its smell is similar to that of turmeric and mango. The perennial herb has a warm-spicy, woody and camphoraceous cineolic odor and bears yellow shiny flowers, with red and green bracts. The ovate leaves possess purple-colored spots and are 1 to 2 feet long, narrowing at the base.

Traditionally the plant is used to for a variety of disease conditions. The paste prepared from the plant is used to treat inflammation, pain, wounds and skin ailments. Power prepared from the dried plant is used to treat menstrual irregularities. The bitter tincture of zedoary rhizome is used for the treatment of recurring diseases like malaria fever. It is also used to treat ulcers.

Previous works investigating analgesic property [10] and anti-inflammatory potential [11] carried out using extracts from different parts of the plant on laboratory animals. Therefore the present study was undertaken employing both in vitro and in vivo methods to explore possible antinociceptive and anti-inflammatory potential of the ethanolic rhizome extract of Curcuma zedoaria so as to establish a plausible mechanism of action of extract and to justify the traditional uses of this plant.

Methods

Collection and proper identification of the plant sample

The plant was Curcuma zedoaria. It was collected from Savar, Bangladesh during the month of February. The whole plant was collected and sun dried. The plant was identified by the experts of Bangladesh National Herbarium (BNH), Mirpur, Dhaka and was given an accession number which was 38765. The specimen was preserved in BNH.

Preparation of powdered plant material

The collected plant was washed with water, separated from undesirable materials. They were put under sunshade to be partially dried. Then they were heated through oven to be fully dried at below 40°C for two days. The fully dried leaves were then grinded to make them powder by the help of a suitable grinder. The powder obtained was extracted via the method of cold extraction using ethanol and then kept for a period of 5 days accompanying occasional shaking and stirring. The whole mixture then underwent a coarse filtration through a piece of clean, white cotton material followed by a second filtration through Whatman no. 1 filter paper. The filtrate (ethanol extract) obtained was evaporated by rotary evaporator (Bibby RE-200, Sterilin Ltd., UK) at 5 to 6 rpm and at 68°C temperature. It rendered a gummy concentrate of dark greenish-black color that was designated as crude ethanolic extract. The extract was finally dried by a freeze drier and preserved.

Animals

Young Swiss-Albino mice aged about 4–5 weeks with average weight of 25–35 gm and adult Long Evans Rats of either sex having average weight of 100–130 gm were used for the experiment and maintained in the animal house of the Department of Pharmacy, North South University for acclimation. The animals were originally obtained from International Centre for Diarrheal Disease Research, Bangladesh (ICDDR, B). They were housed in standard cages under standard environmental conditions of room temperature at 24 ± 1°C and 55-65% relative humidity with 12 hour dark light cycle and provided with standard food for rodents and water ad libitum. The experimental protocol was approved by the Ethics committee of the North South University and was performed according to the Guidelines for Animal experimentation established by the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B).

Method for phytochemical analysis

The freshly prepared extract of C. zedoaria was qualitatively tested for the presence of chemical constituents. Qualitative phytochemical tests for the identification of alkaloids, flavonoids, steroids, gum and carbohydrates, saponins, reducing sugar, tannins and terpenoids were carried out for the extract by the method described previously [12].

Method for the evaluation of analgesic effect

Hot plate test

The hot-plate test (Hot/Cold Plate Model-35100-001, UGO Basile, Italy) was employed for measurement of analgesic activity as previously described by Lanhers et al. and modified by Ojewole [13, 14]. The temperature was regulated at 55° ± 1°C. Mice of either sex were divided into four groups consisting of six animals in each group. The mice of each group were placed in the beaker (on the hot plate) in order to obtain its response to electrical heat induced pain stimulus. Licking of the paws or jumping out of the beaker was taken as an indicator of the animal’s response to heat-induced pain stimulus. The time for each mouse to lick its paws or jump out of the beaker was taken as reaction time (in second). Before treatment, the reaction time was taken once. The mean of this determination constituted initial reaction time before treatment of each group of mice. Each of the test mice was thereafter treated with either distilled water (DW), Diclofenac sodium (10 mg/kg BW) or ethanol extract of C. zedoaria at the doses of 250 and 500 mg/kg BW orally. Thirty minutes after treatment, the reaction times of each group of mice were again evaluated five times individually on one hour interval. Percent analgesic score was calculated as,
Percent Analgesic Score = T a - T b T a × 100

Where, T b  = Reaction time (in second) before drug administration; T a  = Reaction time (in second) after drug administration.

Acetic acid-induced writhing method

The analgesic activity of the sample was evaluated using acetic acid induced writhing method in mice following the method of Koster et al. with slight modification [1517]. In this method, acetic acid is administered intraperitoneally to the experimental animals to create pain sensation. The animals were divided into four groups with six mice in each group. Group I animals received distilled water, Group II received Diclofenac sodium at 10 mg/kg while animals of Group III and Group IV were treated with 250 and 500 mg/kg of the ethanol extract of C. zedoaria after an overnight fast. Test samples and vehicle were administered orally 30 minutes prior to intraperitoneal administration of 0.7% v/v acetic acid solution. Animals were kept individually under glass jar for observation. Each mouse of all groups was observed individually for counting the number of writhing they made in 10 minutes commencing just 5 minutes after the intraperitoneal administration of acetic acid solution. Full writhing was not always accomplished by the animal, because sometimes the animals started to give writhing but they did not complete it. This incomplete writhing was considered as half-writhing. Accordingly, two half-writhings were taken as one full writhing. The number of writhes in each treated group was compared to that of a control group where Diclofenac sodium was used as a reference standard (positive control). The percentage inhibition of writhing was calculated as follows:
% Inhibition = 1 - VT VC × 100

VT = number of writhing motions in extract-treated mice.

VC = number of writhing motions in the control group of mice.

Formalin induced writhing test

The method used was similar to that described previously [18, 19]. The mice were divided into four groups each containing 6 mice and were administered with either distilled water (1 ml/kg, i.p.), ethanolic extract of C. zedoaria (250 and 500 mg/kg, i.p) or Diclofenac sodium (10 mg/kg, s.c). Thirty minutes after this treatment; 50 μL of a freshly prepared 0.6% solution of formalin was injected subcutaneously under the plantar surface of the left hind paw of each mice. The mice were placed individually in an observation chamber and monitored for one hour. The time (in second) spent in licking and biting responses of the injected paw was taken as an indicator of pain response. Anti-nociceptive effect was determined in two phases. The early phase (phase 1) was recorded during the first 5 minutes, while the late phase (phase 2) was recorded during the last 20–30 minutes after formalin injection.

Method for the evaluation of anti-inflammatory effect

Evaluation of in vivo anti-inflammatory effect

The anti-inflammatory activity of the ethanol extract was investigated on carrageenan induced inflammation in rat paw following an established method [20]. Rats were randomly divided into four groups, each consisting of six animals, of which group I was kept as control giving only distilled water. Group II was standard which received Diclofenac sodium (10 mg/kg) as the reference standard for comparison while Group III and Group IV were given the test material at a dose of 250 and 500 mg/kg body weight respectively. Half an hour after the oral administration of the test materials, 1% carrageenan was injected to the right hind paw of each animal. The volume of paw edema was measured at 0, 1, 2, 3, 6 and 9 hours using Plethysmometer (Model 7141, UGO Basile, Italy) after administration of carrageenan. The left hind paw served as a reference non-inflamed paw for comparison.

The average percent increase in paw volume with time was calculated and compared against the control group. Percent inhibition was calculated using the formula-
% Inhibition of paw edema = V c - V t V c × 100

Where, V c and V t represent average paw volume of control and treated animal respectively.

Evaluation of in vitro anti-inflammatory activity

The reaction mixture (5 mL) consisted of 0.2 mL of egg albumin (from fresh hen’s egg), 2.8 mL of phosphate buffered saline (PBS, pH 6.4) and 2 mL of varying concentrations of extract so that final concentrations become 100, 200, 300, 400, 500 μg/mL. Similar volume of double-distilled water served as control. Then the mixtures were incubated at (37°C ± 2) in a BOD incubator (Lab line Technologies) for 15 min and then heated at 70°C for 5 min. After cooling, their absorbance was measured at 660 nm (SHIMADZU, UV 1800) by using vehicle as blank. Acetyl salicylic Acid at the final concentration of (100, 200, 300, 400, 500μg/mL) was used as reference drug and treated similarly for determination of absorbance.

The percentage inhibition of protein denaturation was calculated by using the following formula:
% Inhibition = Ab s control - Ab s test Ab s control × 100

Statistical analysis

The data are expressed as the mean ± SEM analyzed by one-way analysis of variance (ANOVA) and Dunnett’s t-test was used as the test of significance. P value <0.05 was considered as the minimum level of significance. All statistical tests were carried out using SPSS statistical software.

Results

Phytochemical analysis

Phytochemical screening of ethanol extract of C. zedoaria revealed the presence of various bioactive components of which tannins, saponins, gums & carbohydrates, reducing sugar, alkaloid, steroids and terpenoids were the most prominent. The result of phytochemical test has been summarized in the Table 1.
Table 1

Qualitative analysis of the phytochemicals of Curcuma zedoaria

Plant in extract

Tannins

Flavonoids

Saponins

Gums carbohydrate

Steroids

Alkaloids

Reducing sugar

Terpenoids

Ethanolic rhizome extract of Curcuma zedoaria

+++

++

+++

+++

+++

+++

+++

+++

Symbol (+++) indicates presence in high concentration, Symbol (++) indicates presence in moderate concentration, Symbol (+) indicates presence in trace concentration.

Analgesic activity

Hot plate method

Results of hotplate test are presented in Table 2 and Table 3 for the crude extract of C. zedoaria. The rhizome extract of the plant significantly increased the reaction time of heat sensation in mice at the doses of 250 and 500 mg/kg BW and the percentage protection is almost equivalent to the respective doses (Figure 1). In the 3rd hour of study, the extract increased the reaction time of heat sensation to 61.99% and 78.22% at the doses of 250 and 500 mg/kg BW respectively while that of the standard drug was 74% and the results were found to be highly statistically significant (P < 0.001). The extract exhibited a dose dependent increase in latency time when compared with control (Figure 2).
Table 2

Analgesic activity study of the ethanol extract of Curcuma zedoaria using the hot plate method

Treatment

0 min

30 min

60 min

120 min

180 min

240 min

Control

10.70 ± 0.84676

9.6600 ± 0.93680

8.0000 ± 0.81425

6.5800 ± 0.64062

5.5200 ± 0.54900

5.0000 ± 0.44272

Standard

9.1400 ± 0.52402

11.0200 ± 1.00170*

12.6000 ± 0.94499***

14.1600 ± 1.07638***

15.9600 ± 0.67646***

12.4800 ± 0.69814**

Drug250 mg/kg

8.4200 ± 0.34409

9.7400 ± 0.42261

10.9800 ± 0.37336*

12.1800 ± 0.15620***

13.6400 ± 0.22045***

11.2100 ± 0.025768**

Drug500 mg/kg

7.4400 ± 0.60795

8.9200 ± 0.48724

10.4000 ± 0.43012*

12.0000 ± 0.20494***

13.2600 ± 0.14697***

10.0000 ± 0.24819**

All values are Mean ± SEM, n = 5. One way Analysis of Variance (ANOVA) followed by Dennett’s test was performed as the test of significance. The minimum value of p < 0.05 was considered significant. **p < 0.01, ***p < 0.001 as compared with control group.

Table 3

Percentage inhibition of Curcuma zedoaria at different time intervals

Treatment group

% inhibition

½ Hour

1 Hour

2 Hours

3 Hours

4 Hours

Standard

20.56

37.85

54.92

74.61

36.54

250 mg/kg Extract

15.67

30.40

44.65

61.99

33.13

500 mg/kg extract

19.89

39.78

53.20

78.22

34.4

Figure 1

Comparison graph of Curcuma zedoaria with control and standard.

Figure 2

Graph showing the % of inhibition of the ethanol extract of Curcuma zedoaria using the hot plate method.

Acetic acid-induced writhing test

Inhibition of licking response in mice due to the administration of the test drugs during acetic acid-induced writhing test is shown in Table 4. The oral administration of both doses of C. zedoaria rhizome extract significantly (p < 0.001) attenuated the acetic acid-induced abdominal writhes in mice in a dose dependent fashion (Figure 3). The percent inhibition of writhing response by the extract was 48.28% and 54.02% at 250 and 500 mg/kg doses respectively while the standard Diclofenac sodium (10 mg/kg) showed 64.36% inhibition in comparison with the control (Figure 4).
Table 4

Analgesic activity test of Curcuma zedoaria by Acetic Acid induced

Treatment

Total Writhing Counts

Mean ± SE

% Inhibition

Control

19

11

16

15

26

17.4 ± 2.50

-

Standard

4

6

6

8

7

6.2 ± 0.66***

64.36

250 mg/kg

7

8

10

9

11

9 ± 0.71**

48.28

500 mg/kg

10

8

9

6

7

8 ± 0.71***

54.02

All values are Mean ± SEM, n = 5. One way Analysis of Variance (ANOVA) followed by Dennett’s test was performed as the test of significance. The minimum value of p < 0.05 was considered significant. *p < 0.05, **p < 0.01, ***p < 0.001 as compared with control group.

Figure 3

Comparison curve of analgesic activity of Curcuma zedoaria by acetic acid induced writhing method with control and standard groups.

Figure 4

Percentage inhibition of Curcuma zedoaria by acetic acid induced writhing method with standard.

Formalin-induced writhing test

The effect of the extract of C. zedoaria on formalin induced pain in mice is shown in Table 3. The extract significantly inhibited the licking response in both the early phase (64.04% at 250 mg/kg, p < 0.05 and 64.49% at 500 mg/kg, p < 0.01) and the late phase (58.42% at 250 mg/kg, p < 0.05 and 62.37% at 500 mg/kg, p < 0.01) of the formalin test which were comparable to those of the standard drug (Table 5 & Table 6, Figure 5, Figure 6, Figure 7 & Figure 8). Both these inhibitions were dose dependent.
Table 5

Analgesic activity test of Curcuma zedoaria by formalin induced writhing method

Early phase (0–5 min)

Late phase (20–30 min)

Group

Mean ± SE

Group

Mean ± SE

Control

30.60 ± 5.3

Control

20.20 ± 4.86

Standard

9.8 ± 0.58***

Standard

5.0 ± 0.70***

Drug 250 mg

11.00 ± 0.71***

Drug 250 mg

8.40 ± 0.51**

Drug 500 mg

10.56 ± 0.58***

Drug 500 mg

7.60 ± 0.51***

All values are Mean ± SEM, n = 5. One way Analysis of Variance (ANOVA) followed by Dennett’s test was performed as the test of significance. The minimum value of p < 0.05 was considered significant. **p < 0.01, ***p < 0.001 as compared with control group.

Table 6

Percentage inhibition of Curcuma zedoaria by formalin induced writhing method (Early phase and late phase)

Early phase (0–5 min)

Late phase (20–30 min)

Treatment

% inhibition

Treatment

% inhibition

Standard

67.97

Standard

75.25

Drug 250 mg

64.04

Drug 250 mg

58.42

Drug 500 mg

64.49

Drug 500 mg

62.37

Figure 5

Comparison curve of Curcuma zedoaria with control group and standard group (Early phase).

Figure 6

Comparison curve of Curcuma zedoaria with control group and standard group (Late phase).

Figure 7

Percentage inhibition graph of Curcuma zedoaria by formic acid (Early phase).

Figure 8

Percentage inhibition graph of Curcuma zedoaria by formic acid (Late phase).

Anti-inflammatory test result

In vivo anti-inflammatory test result

The anti-inflammatory effects of the extract and standard drug are presented in Table 4. In control animals, the subplantar injection of carrageenan produced a local edema that increased progressively to reach a maximal intensity 3 hours after injection (Figure 9 & Figure 10). The oral administration of both doses of the ethanolic rhizome extract of C. zedoaria significantly (p < 0.05, p < 0.01 and p < 0.001) inhibited inflammatory response induced by carrageenan in rats in a dose related manner (Table 7). The most prominent inhibition of 92.02% at 250 mg/kg and 94.67% at 500 mg/kg were observed at the 3rd hour of study after which the inhibitory activity was found to decline (Table 8 & Figure 11). The result was found to be highly statistically significant at 3rd hour after administration of the sample drugs (p < 0.001) (Table 7).
Figure 9

Comparison chart of Anti-inflammatory of Curcuma zedoaria with Control & Standard group.

Figure 10

Graph showing the anti-inflammatory activity of the ethanol extract of Curcuma zedoaria using carrageenan induced rat paw edema method.

Table 7

Anti-inflammatory activity study of the ethanol extract of Curcuma zedoaria using carrageenan induced rat paw edema method

Treatment group

0 hour

1 hour

3 hours

6 hours

9 hours

12 hours

Control

0.7760 ± 0.02600

0.9040 ± 0.03855

1.1560 ± 0.04665

1.3520 ± 0.04247

1.4880 ± 0.03527

1.3700 ± .04159

Standard

0.8080 ± 0.01772

1.2720 ± 0.04521***

1.5820 ± 0.02417***

1.2020 ± 0.03541**

0.9900 ± 0.02608

0.8460 ± .00812

C.zedoaria 250 mg/kg (n = 5)

0.8280 ± .01772

1.1700 ± 0.07530**

1.590 ± 0.03619***

1.2240 ± 0.03043**

1.0940 ± 0.02909

0.8840 ± .02926

C.zedoaria 500 mg/kg (n = 5)

0.7920 ± .03153

1.0580 ± .03541**

1.5420 ± .03441***

1.2660 ± .04069**

0.9940 ± .02638

0.8320 ± .02396

All values are Mean ± SEM, n = 5. One way Analysis of Variance (ANOVA) followed by Dennett’s test was performed as the test of significance. The minimum value of p < 0.05 was considered significant. **p < 0.01, ***p < 0.001 as compared with control group.

Table 8

Percentage inhibition of Curcuma zedoaria at different time intervals

 

% inhibition

Group

1 hour

3 hours

6 hours

9 hours

12 hours

Standard

57.42

95.79

48.76

22.52

5.00

250 mg/kg

44.80

92.02

47.20

32.12

6.76

500 mg/kg

33.56

94.67

59.85

25.13

5.05

Figure 11

Graph showing the % of inhibition of the ethanol extract of Curcuma zedoaria using carrageenan induced rat paw edema method.

In vitro anti-inflammatory result

In the present study for in vitro anti-inflammatory test, the ethanol extract, of C.zedoaria showed mean inhibition of protein denaturation of 77.15, 64.43, 53.04, 36.78 and 23.70% for doses of 500, 400, 300, 200 and 100 μg/mL respectively, whereas, for ASA it was found to be 88.06, 80.25, 77.18, 69.58 and 50.56% for same doses respectively (Table 9 & Figure 12). The ethanolic extracts of C.zedoaria showed good anti-inflammatory activity with a linear response. Maximum inhibition of 77.15 ± 2.93% was observed at 500 μg/mL and standard anti-inflammatory drug (Aspirin) showed the maximum inhibition, 88.06 ± 2.07% at the concentration of 500 μg/mL. The ability of extract of C.zedoaria to inhibit thermal denaturation of protein was found to be statistically significant (p < 0.05). In conclusion, further investigations are needed to identify the active constituents and the exact mechanism(s) of action responsible for the reported analgesic & anti-inflammatory properties of Curcuma zedoaria.
Table 9

Protein denaturation activity of ethanol extracts of Curcuma zedoaria

Sample

Conc.

Mean% inhibition ± SD

(μg/mL)

Standard (Acetyl Salicylic Acid)

500

88.06 ± 2.07***

400

80.25 ± 1.34***

300

77.18 ± 1.45***

200

69.58 ± 0.83***

100

50.56 ± 1.36**

Ethanol Extract of Curcuma zedoaria (Rhizome)

500

77.15 ± 2.93***

400

64.43 ± 4.27***

300

53.04 ± 2.65**

200

36.78 ± 5.16**

100

23.70 ± 3.06*

All values are Mean ± SEM, n = 3. One way Analysis of Variance (ANOVA) followed by Dennett’s test was performed as the test of significance. The minimum value of p < 0.05 was considered significant. *p < 0.05, **p < 0.01, ***p < 0.001 as compared with control group.

Figure 12

Comparison curve of Acetyl Salicylic Acid with Curcuma zedoaria .

Discussion

Phytochemical investigation of the ethanolic rhizome extract of Curcuma zedoaria indicates the presence of tannins, alkaloids, flavonoids, gum and carbohydrates, reducing sugar and terpenoids. The presence of these chemicals represents the possibility of some biological activity of the ethanolic rhizome extract of Curcuma zedoaria.

A variety of pharmacological activities has been attributed to flavonoid compounds. Some flavonoids are reported to have analgesic and anti-inflammatory activities [2123]. Some flavonoids can significantly inhibit a number of inflammatory mediators [24]. Terpenoids also possess significant analgesic and anti-inflammatory activities [25, 26]. Such activity has been attributed to the ability to inhibit phospholipase A2 and thereby ultimately blocking the metabolism of arachidonic acid [27]. A number of alkaloids may also prevent inflammation through blocking the metabolic pathway of arachidonic acid [28, 29].

The hot plate test measures the response to a brief, noxious stimulus having a close resemblance to clinical pain. This test measures the complex feedback to a non-inflammatory, acute nociceptive input and is one of the models normally used for studying central nociceptive activity [30]. The method is considered to be selective for the drugs acting centrally. It is a fact that any agent that causes a prolongation of the hot plate latency using this test must be acting centrally [31]. The ethanolic rhizome extract of C. zedoaria presented a longer latency time than the control group in the hot plate test in a dose related manner. Therefore, the extract has activity on central nervous system.

Acetic acid induced writhing response in mice, associated to visceral pain, finds much attention to evaluate peripherally active analgesics [32]. Pain sensation in acetic acid induced writhing method is obtained by generating localized inflammatory response resulting in release of free arachidonic acid from tissue phospholipid via cyclooxygenase and prostaglandin biosynthesis [33]. The boost in prostaglandin levels within the peritoneal cavity then raises inflammatory pain by rising capillary permeability [34]. The agent lessening the number of twitching will render analgesic effect preferably by restriction of prostaglandin synthesis, a peripheral mechanism of pain inhibition [33]. In the present study, the crude extract produced significant analgesic effect which might be due to the presence of analgesic principles acting with the prostaglandin alley.

The formalin test is a model of continuing pain including peripheral inflammation and central sensitization. The method exhibits a biphasic reaction comprising of an early (neurogenic) and a late (inflammatory) phase reaction and originates mainly from neurogenic inflammation followed by participation of kinins and leukocytes with their pro-inflammatory factors including prostaglandins [35]. It is also reported that acute inflammation convinced by formalin results from cell injury which serves the production of endogenous mediators [36]. Results of the present study show that the plant extract produced antinociception against both neurogenic and inflammatory phase of formalin induction. The fact that the extract at the doses tested produced analgesia in all nociceptive models is indicative that it possesses both central and peripheral antinociceptive effects and the mechanism of action of the extract could, in part, be related to lipooxygenase and/or cyclooxygenase of the arachidonic acid cascade and/or opioid receptors.

Carrageenan-induced inflammation is commonly used model for assessing the anti-inflammatory potency of compounds or natural products [37]. The probable mechanism of action of carrageenan-induced inflammation is bi-phasic, the first phase is characterised by the release of histamine, serotonin and kinins in the first hour; while the second phase is attributed to the release of prostaglandins and lysosome enzymes in 2 to 4 hours [38]. The second phase is sensitive to most clinically valid anti-inflammatory drugs [39]. The results of present study reveal that the extract significantly inhibited the carrageenan-induced acute inflammation in the 3rdhour of study and was comparable to that of the standard diclofenac sodium. So, the anti-inflammatory effect of C. zedoaria extract may be due to its suppressive action on prostaglandin, protease or lysosome synthesis or activity.

The method of anti-denaturation of egg albumin was chosen to evaluate anti-inflammatory property of C.zedoaria. In anti-denaturation assay the denaturation of egg albumin is induced by heat treatment. The denatured protein expresses antigens associated to Type III hyper-sensitive reaction which are related to diseases such as serum sickness, glomerulo-nephritis etc. [40]. Heat-denatured proteins are as effective as native proteins in provoking delayed hypersensitivity [41]. Moreover, it was already proved that conventional NSAID’s like phenylbutazone and indomethazine do not act only by the inhibition of endogenous prostaglandins production by blocking COX enzyme but also by prevention of denaturation of proteins [42]. Thus anti-denaturation assay is the convenient method to check the anti-inflammatory activity. From the result of the present study, the extract has shown considerable anti-inflammatory activity. C.zedoaria is capable of controlling the production of auto antigen and thereby it inhibits the denaturation of proteins and its effect was compared with the standard drug Aspirin. The secondary metabolites like phenolic compounds and tannins which were found in preliminary phytochemical screening might be responsible for this activity.

Conclusion

Based on the present investigation, it can be concluded that the antinociceptive & in-vivo & in-vitro anti-inflammatory activity of the rhizome extract of Curcuma zedoaria might be attributed to the presence of the plant’s various secondary metabolites like tannins, saponins, steroids, alkaloids, reducing sugars, terpenoids and flavonoids. These experimental findings support the traditional use of this plant for the treatment of various ailments especially against pain and inflammatory conditions. However, further investigations are required to isolate the active constituents responsible for the observed effect, and to elucidate the possible mechanisms of action responsible for the antinociceptive and anti-inflammatory activities of the plant extract.

Declarations

Acknowledgement

This work was supported by the pharmacy department of the North South University, Dhaka, Bangladesh.

Authors’ Affiliations

(1)
College of Pharmacy, Gyeongsang National University
(2)
Department of Pharmaceutical Sciences, School of Life Sciences, North South University
(3)
Department of Pharmacy, Faculty of Science and Engineering, Southern University Bangladesh

References

  1. Robinson MR, Zhang X: The World Medicines Situation 2011 (Traditional Medicines: Global Situation, Issues And Challenges). 2011, Geneva: World Health OrganizationGoogle Scholar
  2. Elisabetsky E, Posey DA: Ethnopharmacological research and natural resources of humid tropics: the case of Kayapo’ indians and its implications for medical science. Anais do 10 Simposio do Tro’pico U’ mido. 1986, Brazilian Enterprise for Agricultural Research, Agricultural Research Center of the Humid Tropics, 2: Belem, Brazil, 85-93.Google Scholar
  3. Calixto JB, Beirith A, Ferreira J, Santos ARS, Filho VC, Yunes RA: Naturally occurring antinociceptive substances from plants. Phytother Res. 2000, 14: 401-418. 10.1002/1099-1573(200009)14:6<401::AID-PTR762>3.0.CO;2-H.View ArticlePubMedGoogle Scholar
  4. Soldati F: The Registration Of Medicinal Plant Products, What Quality Of Documentation Should Be Required? The Industrial Point Of View. World Congress on Medicinal and Aromatic Plants for Human Welfare, 2, 1997. 1997, Abstracts. Mendoza: ICMPA/ISHS/SAIPOA, p. L-48Google Scholar
  5. Vulto AG, Smet PAGM: Drugs used in non-orthodox medicine. Meyler’s Side Effects of Drugs. Edited by: Dukes MMG. 1988, Amsterdam: Elsevier, 999-1005. 11Google Scholar
  6. Mendonça-Filho RR: Bioactive Phytocompounds: New Approaches in the Phytosciences. Modern Phytomedicine: Turning Medicinal Plants into Drugs. Edited by: Ahmad I, Aqil F, Owais M. 2006, Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, doi:10.1002/9783527609987.ch1Google Scholar
  7. Patwardhan B, Vaidya ADB, Chorghade M: Ayurveda and natural products drug discovery. Curr Sci. 2004, 86 (6): 789-799.Google Scholar
  8. Ezeugwu CO, Okonta JM, Nwodo NJ: Antidiabetic properties of ethanolic fruit extract of Solanumaethiopicum L. Res J Pharmaceut Allied Sci. 2004, 2 (2): 251-254.Google Scholar
  9. Read MA: Flavonoids: naturally occurring anti-inflammatory agents. Am J Pathol. 1995, 147: 235-237.PubMedPubMed CentralGoogle Scholar
  10. Das K, Rahman MA: Analgesic and antimicrobial activities of Curcuma zedoaria. Int J Pharm Sci. 2012, 4 (Suppl 5): 322-328.Google Scholar
  11. Kaushik M, Jalalpure SS: Anti­inflammatory efficacy of Curcuma zedoaria rosc root extracts. Asian J Pharm Clin Res. 2011, 4 (3): 90-92.Google Scholar
  12. Harborne JB: Phytochemical Methods:A Guide To Modern Techniques Of Plant Analysis. 1998, London: Chapman and Hall, ISBN: 0-412-57270-2, pp. 302, 3Google Scholar
  13. Lanhers M-C, Fleurentin J, Mortier F, Vinche A, Younos C: Anti-inflammatory and analgesic effects of an aqueous extract of Harpagophytum procumbens. Planta Med. 1992, 58: 117-123. 10.1055/s-2006-961411.View ArticlePubMedGoogle Scholar
  14. Ojewole JAO: Evaluation of the analgesic, anti-inflammatory and anti-diabetic properties of Sclerocarya birrea (A. Rich.) Hochst. Stem-bark aqueous extract in mice and rats. Phytother Res. 2004, 18: 601-608. 10.1002/ptr.1503.View ArticlePubMedGoogle Scholar
  15. Koster R, Anderson M, De Beer EJ: Acetic acid for analgesic screening. Fed Proc. 1959, 18: 412-Google Scholar
  16. Owoyele BV, Olaleye SB, Oke JM, Elegbe RA: Anti-inflammatory and analgesic activities of leaf extracts of Landolphia owariensis. Afr J Biomed Res. 2001, 4: 131-133.Google Scholar
  17. Altun ML, Çitoğlu GS, Yılmaz BS, Özbek H: Antinociceptive and anti-inflammatory activities of Viburnum opulus. Pharm Biol. 2009, 47: 653-658. 10.1080/13880200902918345.View ArticleGoogle Scholar
  18. Shibata M, Ohkubo T, Takahashi H, Inoki R: Modified formalin test: characteristic biphasic pain response. Pain. 1989, 38: 347-352. 10.1016/0304-3959(89)90222-4.View ArticlePubMedGoogle Scholar
  19. Viana GSB, Do Vale TG, Rao VSN, Matos FJA: Analgesic and antiinflammatory effects of two chemotypes of Lippia Alba: a comparative study. Pharm Biol. 1998, 36: 347-351. 10.1076/phbi.36.5.347.4646.View ArticleGoogle Scholar
  20. Winter CA, Risley EA, Nuss GW: Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc Soc Exp Biol Med. 1962, 111: 544-547. 10.3181/00379727-111-27849.View ArticlePubMedGoogle Scholar
  21. Rao MR, Rao YM, Rao AV, Prabhkar MC, Rao CS, Muralidhar N: Antinociceptive and anti-inflammatory activity of a flavonoid isolated from Caralluma attenuate. J Ethnopharmacol. 1998, 62: 63-66. 10.1016/S0378-8741(98)00048-8.View ArticlePubMedGoogle Scholar
  22. Kim HP, Son KH, Chang HW, Kang SS: Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci. 2004, 96: 229-245. 10.1254/jphs.CRJ04003X.View ArticlePubMedGoogle Scholar
  23. Küpeli E, Yesilada E: Flavonoids with anti-inflammatory and antinociceptive activity from Cistuslaurifolius L. leaves through bioassay-guided procedures. J Ethnopharmacol. 2007, 112: 524-530. 10.1016/j.jep.2007.04.011.View ArticlePubMedGoogle Scholar
  24. Middleton E: Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol. 1998, 439: 175-182. 10.1007/978-1-4615-5335-9_13.View ArticlePubMedGoogle Scholar
  25. Neukirch H, D’Ambrosio M, Sosa S, Altinier G, Loggia RD, Guerriero A: Improved anti-inflammatory activity of three new terpenoids derived, by systematic chemical modifications, from the abundant triterpenes of the flowery plant Calendula officinalis. Chem Biodivers. 2005, 2 (5): 657-671. 10.1002/cbdv.200590042.View ArticlePubMedGoogle Scholar
  26. Moody JO, Robert VA, Connolly JD, Houghton PJ: Anti-inflammatory activities of the methanol extracts and an isolated furanoditerpene constituent of Sphenocentrumjollyanum Pierre (Menispermaceae). J Ethnopharmacol. 2006, 104: 87-91. 10.1016/j.jep.2005.08.051.View ArticlePubMedGoogle Scholar
  27. Barar FSK: Essentials of Pharmacology, 3rd (ed). 2000, New Delhi: S. Chad and Company, 1171-3137.Google Scholar
  28. Barik BR, Bhowmik T, Dey AK, Patra A, Chatterjee A, Joy S, Susan T, Alam M, Kundu AB: Premnazole and isoxazole alkaloid of Premaintegrifolia and Gmelinaarborea with anti-inflammatory activity. Fitoterapia. 1992, 53: 295-299.Google Scholar
  29. Chao J, Lu T-C, Liao J-W, Huang T-H, Lee M-S, Cheng H-Y, Ho L-K, Kuo C-L, Peng W-H: Analgesic and anti-inflammatory activities of ethanol root extract of Mahoniaoiwakensis in mice. J Ethnopharmacol. 2009, 125: 297-303. 10.1016/j.jep.2009.06.024.View ArticlePubMedGoogle Scholar
  30. Sabina E, Chandel S, Rasool MK: Evaluation of analgesic, antipyretic and ulcerogenic effect of Withaferin A. Int J Integr Biol. 2009, 6 (2): 52-56.Google Scholar
  31. Ibironke GF, Ajiboye KI: Studies on the anti–inflammatory and analgesic properties of Chenopodium ambrosioides leaf extract in rats. Int J Pharmacol. 2007, 3: 111-115.View ArticleGoogle Scholar
  32. Hasan SMR, Hossain MM, Akter R, Jamila M, Mazumder MEH, Alam MA, Faruque A, Rana S, Rahman S: Analgesic activity of the different fractions of the aerial parts of Commelina benghalensis Linn. Int J Pharmacol. 2010, 6 (1): 63-67.View ArticleGoogle Scholar
  33. Duarte IDG, Nakamura M, Ferreira SH: Participation of the sympathetic system in acetic acid-induced writhing in mice. Braz J Med Biol Res. 1988, 21: 341-343.PubMedGoogle Scholar
  34. Zakaria ZA, Ghani ZDFA, Nor RNSRM, Gopalan HK, Sulaiman MR, Jais AMM, Somchit MN, Kader AA, Ripin J: Antinociceptive, anti-inflammatory, and antipyretic properties of an aqueous extract of Dicranopteris linearis leaves in experimental animal models. J Nat Med. 2008, 62: 179-187. 10.1007/s11418-007-0224-x.View ArticlePubMedGoogle Scholar
  35. Wheeler-Aceto H, Cowan A: Neurogenic and tissue mediated components of formalin induced edema agents actions. Fitoterapia. 1991, 34: 264-Google Scholar
  36. Chen Y-F, Tsai H-Y, Wu T-S: Anti-inflammatory and analgesic activities form roots of Angelica pubescens. Planta Med. 1995, 61: 2-8. 10.1055/s-2006-957987.View ArticlePubMedGoogle Scholar
  37. El-Shenawy SM, Abdel-Salam OME, Baiuomy AR, El-Batran S, Arbid MS: Studies on the anti-inflammatory and antinociceptive effects of Melatonin in the rat. Pharmacol Res. 2002, 46: 235-243. 10.1016/S1043-6618(02)00094-4.View ArticlePubMedGoogle Scholar
  38. Brooks PM, Day RO: Non-steroidal anti-inflammatory drugs - differences and similarities. New Eng J Med. 1991, 324: 1716-1725. 10.1056/NEJM199106133242407.View ArticlePubMedGoogle Scholar
  39. Vinegar R, Schreiber W, Hugo R: Biphasic development of carrageenin edema in rats. J Pharmacol Exp Ther. 1969, 166: 96-103.PubMedGoogle Scholar
  40. Ahmad F, Khan RA, Rasheed S: Study of analgesic and anti-inflammatory activity from plant extracts of Lactuca scariola and Artemisia absinthium. J Islamia Acad Sci. 1992, 5: 111-114.Google Scholar
  41. Gell PGH, Benacerraf B: Studies on hypersensitivity-II delayed hypersensitivity to denatured proteins in guinea pig. Immunology. 1959, 2: 64-PubMedPubMed CentralGoogle Scholar
  42. Insel PA: Analgesic-Antipyretics and Antiinflammatory Agents: Drugs Employed in the Treatment of Rheumatoid Arthritis and Gout. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. Edited by: Gilman AG, Rall T, Nies A, Taylor P. 1990, Pergamon, NY, 638-681.Google Scholar
  43. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/14/346/prepub

Copyright

© Ullah et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement